Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First Roche, Then Bristol: Who’s Next?

Aug 07 2008

Related Content

Wyeth/Progenics’ Relistor Fails Second Phase III POI Study

May 22 2008

Adolor/GSK’s Entereg Approved By FDA

May 20 2008

Sanofi/Regeneron’s Aflibercept Misses Mark In Phase II Ovarian Cancer Trial

May 21 2008

Sanofi Offers $2.5B For Zentiva

Jun 18 2008

Sanofi Pasteur Nets Flu Vaccine Via Acambis Purchase

Jul 25 2008

Wyeth/Progenics’ Relistor: FDA Says Yes, EU Likes It, Too

Apr 24 2008

Wyeth Gains Phase III Candidate For Treatment Of Opioid Side Effects From Progenics

Dec 23 2005

Sanofi Strengthens Monoclonal Antibody Access With $560 Million Regeneron Deal

Nov 29 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window